Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD‐02 study design and first results

Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD‐02 study design and first results

Primary prevention of type 1 diabetes (T1D) requires intervention in genetically at‐risk infants. The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) has established a screening program, GPPAD‐02, that identifies infants with a genetic high risk of T1D, enrolls these into primary p...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Winkler, C, Haupt, F, Heigermoser, M, Zapardiel-Gonzalo, J, Ohli, J, Faure, T, Kalideri, E, Hommel, A, Delivani, P, Berner, R, Kordonouri, O, Roloff, F, Von Dem Berge, T, Lange, K, Oltarzewski, M, Glab, R, Szypowska, A, Snape, M, Vatish, M, Todd, J, Larsson, H, Ramelius, A, Kördel, J, Casteels, K, Paulus, J, Ziegler, A, Bonifacio, E, GPPAD Study Group
פורמט: Journal article
שפה:English
יצא לאור: Wiley 2019

פריטים דומים